Dr. Thomas M. Kilkenny, DO

Dr. Kilkenny practices at Staten Island University Hospital - North Campus in Staten Island, New York.

Dr. Kilkenny's NPI, 1023084787, was assigned on February 23, 2006. Dr. Kilkenny graduated from Philadelphia College of Osteopathic Medicine in 1990. Dr. Kilkenny holds New York license 189698.

Dr. Kilkenny's primary practice is Staten Island University Hospital - North Campus, at 475 Seaview Ave, Staten Island, NY 10305 in Richmond County. The practice phone is (718) 226-4502.

Dr. Kilkenny's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Dr. Kilkenny is also affiliated with Staten Island University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Kilkenny to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kilkenny practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kilkenny's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kilkenny is licensed in New York.

CMS data shows 2,874 Medicare services from Dr. Kilkenny across 18 procedure codes in 2024, for 1,164 Medicare patients. Medicare paid $243,348 for them.

CMS counts 1,164 Medicare patients who saw Dr. Kilkenny in 2024. The largest group is 65 to 74, with 498 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kilkenny's median patient age at 63, with 38% women.

In 2024, Dr. Kilkenny wrote 2,852 Medicare Part D claims for 465 patients. 50% of them were for generic drugs. CMS names the drug for 2,682 of them, across 32 drugs with 11 or more claims each, at $1,146,810 in total drug cost. In 2023, CMS named 2,612 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kilkenny for performance year 2024, reported through an alternative payment model (APM). Dr. Kilkenny accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kilkenny as offering telehealth.

Dmand AI links 4 papers to Dr. Kilkenny, published from 2012 to 2023. 2012 was the busiest year, with 2. Dr. Kilkenny has published most often in Cureus. Dr. Kilkenny's most frequent co-authors are Homam Alkaied, MD, Michel Nabih Chalhoub, MD and Dany E. Elsayegh, MD.

CMS Open Payments shows 27 general payments to Dr. Kilkenny from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. GlaxoSmithKline, LLC. paid the most, $475.

Dr. Kilkenny graduated from Philadelphia College of Osteopathic Medicine in 1990.